NDC 50268-515-11 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50268-515
- Requested NDC
- 50268-515-11
- Package NDCs from labels
- 50268-515-11, 50268-515-15
- Manufacturer
- AvPAK | Torrent Pharma, Inc.
- Effective date
- 2019-08-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - AvPAK | Torrent Pharma, Inc. | AvPAK | Torrent Pharma, Inc. | 2019-08-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-515-11 | EA - Each | 50268-515 | 7040bb8d-802d-4fd5-b1f7-a72d242b5105 | 1 | 2015-04-03 |
| 50268-515-15 | EA - Each | 50268-515 | 271cf977-eae9-42c2-8a8f-a444845a63e7 | 1 | 2014-10-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET [AVPAK] | 2 | |
| LOSARTAN POTASSIUM | ACTIVE INGREDIENT | 3ST302B24A | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET [AVPAK] | 2 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET [AVPAK] | 2 | |
| LOSARTAN | ACTIVE MOIETY | JMS50MPO89 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET [AVPAK] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET [AVPAK] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | c80b36c2-fa22-e7a9-e053-2a95a90ae21e | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | 16a6a582-eb4d-41bc-9d49-fc1d4117b29a | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | QPharma, Inc. | c80b3a28-ef15-5902-e053-2995a90a06d7 | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50 | TITANIUM DIOXIDE, ZINC OXIDE | COOLA, LLC | cb95c712-1680-4040-e053-2995a90af004 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | c182b6a9-1a31-45ee-9cea-a557c99f5db7 | 2026-11-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | 303d5d5a-4c7a-1e23-e063-6294a90a0e58 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | EAI-JR 286, Inc. | b9ea12e8-6ed9-d805-e053-2a95a90aa107 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Pearl White Face Stick SPF 50 | PADIMATE O, TITANIUM DIOXIDE | Eai-jr 286, Inc | b69a75e0-8724-35ae-e053-2a95a90a5f34 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra S Dorian Kona Gold Signature Face Stick SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | b6c316c3-661b-6428-e053-2a95a90a1a6b | 2026-11-04 | Warnings | 15FIX9V2JP |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2026-11-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd | 2026-11-03 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98a58b54-bcf2-4726-800a-facf48d9155f | 2026-11-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | 6f39f7f9-edac-45ca-9ee2-c2ecad0915ab | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 1dc47186-3ecf-456f-b6d6-ba0f75c2504b | 2026-11-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Coupler LLC | 5f4e3bc8-2810-f1ae-e063-6394a90a9725 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium | LOSARTAN POTASSIUM | St. Mary's Medical Park Pharmacy | 5f678784-a3d1-d9f7-e063-6294a90aed48 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40f46b-c6b2-df1f-e063-6394a90afd96 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.